California Made a Big Bet on Producing Its Own Insulin, But There’s No ‘Date Certain’ for Delivery
During a hearing, representatives for the Newsom administration said they could not provide a timeline for when ...
Dying to be thin? The FDA must regulate counterfeit weight loss drugs, says AG Bonta | Opinion
More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...
ABC712d
California bill introduced in effort to ban sale of anti-aging products to shoppers under 18
Tween trendsetters have taken over social media with skin care routines inspiring other young kids. The proposal is a ...
NBC Los Angeles8d
How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it
Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...
FDA Moves to Rehire Medical Device, Food Safety and Other Staffers Fired Days Earlier
The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...
Sierra Sun Times10d
California Attorney General Bonta: FDA Should Take Quick and Decisive Action Against Makers of Counterfeit Weight Loss Drugs
As part of a bipartisan coalition of 38 states and territories, California Attorney General Rob Bonta today urged the Food and Drug Administration (FDA) to take swift and decisive action against bad ...
New York Post4d
Popular lemonade recalled by FDA for cancer-linked chemical
The affected products were distributed in Arkansas, California, Colorado, Kentucky, Missouri, New Mexico, Oklahoma, and Texas. The FDA classified this recall as a Class II risk, which indicates a ...
FDA: Nationwide listeria outbreak leads to 12 deaths
A total of 38 listeria monocytogenes infections have been reported in New York, California and about 20 other states, according to the FDA.
GlobalData on MSN7d
FDA approves Medtronic’s brain stimulation system for Parkinson’s
Medtronic has received approval from the FDA for BrainSense, its aDBS therapy for patients living with Parkinson’s disease.